Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
CTMXCytomX Therapeutics, Inc.
| Figure | CTMXCytomX Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $76.20M |
| Revenue, yoy | −44.8% |
| Net income | $17.37M |
| Net income, yoy | −154.5% |
| Net margin | -22.8% |
| Free cash flow | $75.81M |
| FCF margin | -99.5% |
| EPS, diluted | $0.15 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed